Are you Dr. Goldberg?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 8 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Sacramento, CA 95817Phone+1 916-734-8252- Is this information wrong?
Summary
- Dr. Zelanna Goldberg, MD is a radiation oncologist in Sacramento, California. She is currently licensed to practice medicine in California.
Education & Training
University of Toronto Faculty of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1998 - 2026- American Board of Radiology Radiation Oncology
Clinical Trials
- Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer Start of enrollment: 2003 Sep 01
- Radiation Therapy, Bevacizumab, Paclitaxel, and Carboplatin in Treating Patients With Unresectable Stage IIIB or Stage IV Non-Small Cell Lung Cancer at High Risk for Hemoptysis Caused by Bevacizumab Start of enrollment: 2006 Oct 01
Publications & Presentations
PubMed
- 47 citationsCombined Pan-HER and ALK/ROS1/MET Inhibition with Dacomitinib and Crizotinib in Advanced Non–Small Cell Lung Cancer: Results of a Phase I StudyPasi A. Jänne, Alice T. Shaw, D. Ross Camidge, Giuseppe Giaccone, S. Martin Shreeve
Journal of Thoracic Oncology. 2016-05-01 - 34 citationsA phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer.Henry Wang, J. Ryu, David R. Gandara, Richard J. Bold, Shiro Urayama
Journal of Thoracic Oncology. 2007-02-01 - 108 citationsDacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): A randomised, double-blind, phase 3 trialSuresh S. Ramalingam, Pasi A. Jänne, Tony Mok, Kenneth J. O'Byrne, Michael Boyer
The Lancet. Oncology. 2014-11-01
Press Mentions
Alpine Immune Sciences Provides Corporate Update and Reports Second Quarter 2021 Financial ResultsAugust 10th, 2021- Alpine Immune Sciences Appoints Zelanna Goldberg, M.D., M.A.S. As Chief Medical OfficerJune 2nd, 2021
